Table 5 Characteristics of patients before and after PSM between group A and group B.

From: Study on the survival prognosis of over 80 years old patients of esophageal cancer with other cancers-based on SEER data analysis

Variable

Before PSM (n, %)

P

After PSM (n, %)

P

Total

(n = 2244)

Group A

(n = 245)

Group B

(n = 1999)

Total

(n = 482)

Group A

(n = 241)

Group B

(n = 241)

Age

   

0.006

   

0.949

 80–84 years

1281(57.09)

163 (66.53)

1118 (55.93)

 

315 (65.35)

159 (65.98)

156 (64.73)

 

 85–89 years

661(29.46)

59 (24.08)

602 (30.12)

 

119 (24.69)

58 (24.07)

61 (25.31)

 

 ≥ 90 years

302(13.46)

23 (9.39)

279 (13.96)

 

48 (9.96)

24 (9.96)

24 (9.96)

 

Sex

   

0.685

   

0.316

 Male

1564 (69.70)

168 (68.57)

1396 (69.83)

 

342 (70.95)

166 (68.88)

176 (73.03)

 

 Female

680 (30.3)

77 (31.43)

603 (30.17)

 

140 (29.05)

75 (31.12)

65 (26.97)

 

Marital status

  

0.743

   

0.676

 Married

1108 (49.38)

126 (51.43)

982 (49.12)

 

242 (50.21)

124 (51.45)

118 (48.96)

 

 Single

1020 (45.45)

108 (44.08)

912 (45.62)

 

214 (44.4)

106 (43.98)

108 (44.81)

 

 Unknown

116 (5.17)

11 (4.49)

105 (5.25)

 

26 (5.39)

11 (4.56)

15 (6.22)

 

Race

   

0.165

   

0.441

 White

2036 (90.73)

215 (87.76)

1821 (91.10)

 

418 (86.72)

211 (87.55)

207 (85.89)

 

 Asian

133 (5.93)

21 (8.57)

112 (5.60)

 

49 (10.17)

21 (8.71)

28 (11.62)

 

 Black

75 (3.34)

9 (3.67)

66 (3.30)

 

15 (3.11)

9 (3.73)

6 (2.49)

 

Location

   

0.080

   

0.923

 Cervical

239 (10.65)

26 (10.61)

213 (10.66)

 

55 (11.41)

26 (10.79)

29 (12.03)

 

 Thoracic

473 (21.08)

64 (26.12)

409 (20.46)

 

120 (24.9)

62 (25.73)

58 (24.07)

 

 Abdomen

1208 (53.83)

130 (53.06)

1078 (53.93)

 

254 (52.7)

128 (53.11)

126 (52.28)

 

 Unknown

324 (14.44)

25 (10.20)

299 (14.96)

 

53 (11)

25 (10.37)

28 (11.62)

 

Size

   

0.168

   

0.976

 1–3 cm

546 (24.33)

71 (28.98)

475 (23.76)

 

184 (38.17)

91 (37.76)

93 (38.59)

 

 4–6 cm

468 (20.86)

48 (19.59)

420 (21.01)

 

178 (36.93)

91 (37.76)

87 (36.10)

 

 7–9 cm

254 (11.32)

32 (13.06)

222 (11.11)

 

72 (14.94)

36 (14.94)

36 (14.94)

 

 ≥10 cm

976 (43.49)

94 (38.37)

882 (44.12)

 

48 (9.96)

23 (9.54)

25 (10.37)

 

Histology

   

0.230

   

0.587

 Adenocarcinoma

1214 (54.10)

120 (48.98)

1094 (54.73)

 

242 (50.21)

118 (48.96)

124 (51.45)

 

 Squamous

876 (39.04)

107 (43.67)

769 (38.47)

 

202 (41.91)

106 (43.98)

96 (39.83)

 

 Others

154 (6.86)

18 (7.35)

136 (6.80)

 

38 (7.88)

17 (7.05)

21 (8.71)

 

Grade

   

0.822

   

0.457

 G1

248 (11.05)

29 (11.84)

219 (10.96)

 

62 (12.86)

34 (14.11)

28 (11.62)

 

 G2

848 (37.79)

95 (38.78)

753 (37.67)

 

187 (38.80)

97 (40.25)

90 (37.34)

 

 G3 + G4

1148 (51.16)

121 (49.39)

1027 (51.38)

 

233 (48.34)

110 (45.64)

123 (51.04)

 

Stage

   

0.001

   

0.613

 Local

778 (34.67)

112 (45.71)

666 (33.32)

 

207 (42.95)

103 (42.74)

104 (43.15)

 

 Regional

1015 (45.23)

94 (38.37)

921 (46.07)

 

182 (37.76)

95 (39.42)

87 (36.10)

 

 Distant

451 (20.10)

39 (15.92)

412 (20.61)

 

93 (19.29)

43 (17.84)

50 (20.75)

 

T Stage

   

0.220

   

0.996

 T1

755 (33.65)

80 (32.65)

675 (33.77)

 

136 (28.22)

67 (27.80)

69 (28.63)

 

 T2

260 (11.59)

35 (14.29)

225 (11.26)

 

64 (13.28)

32 (13.28)

32 (13.28)

 

 T3

647 (28.83)

77 (31.43)

570 (28.51)

 

152 (31.54)

77 (31.95)

75 (31.12)

 

 T4

582 (25.94)

53 (21.63)

529 (26.46)

 

130 (26.97)

65 (26.97)

65 (26.97)

 

N Stage

   

0.443

   

0.927

 N0

1460 (65.06)

154 (62.86)

1306 (65.33)

 

275 (57.05)

137 (56.85)

138 (57.26)

 

 N+

784 (34.94)

91 (37.14)

693 (34.67)

 

207 (42.95)

104 (43.15)

103 (42.74)

 

M Stage

   

0.073

   

0.578

 M0

1671 (74.47)

194 (79.18)

1477 (73.89)

 

379 (78.63)

192 (79.67)

187 (77.59)

 

 M+

573 (25.53)

51 (20.82)

522 (26.11)

 

103 (21.37)

49 (20.33)

54 (22.41)

 

CDS

   

0.000

   

0.443

 Yes

299 (13.32)

55 (22.45)

244 (12.21)

 

107 (22.20)

50 (20.75)

57 (23.65)

 

 No

1945 (86.68)

190 (77.55)

1755 (87.79)

 

375 (77.80)

191 (79.25)

184 (76.35)

 

Radiotherapy

  

0.508

   

0.900

 Yes

2133 (95.05)

235 (95.92)

1898 (94.95)

 

407 (84.44)

204 (84.65)

203 (84.23)

 

 No

111 (4.95)

10 (4.08)

101 (5.05)

 

75 (15.56)

37 (15.35)

38 (15.77)

 

Chemotherapy

  

< 0.001

   

0.228

 Yes

698 (31.11)

109 (44.49)

589 (29.46)

 

197 (40.87)

105 (43.57)

92 (38.17)

 

 No/Unknown

1546 (68.89)

136 (55.51)

1410 (70.54)

 

285 (59.13)

136 (56.43)

149 (61.83)

 

CDS + RT

   

0.022

   

0.687

 Yes

80 (3.57)

15 (6.12)

65 (3.25)

 

26 (5.39)

14 (5.81)

12 (4.98)

 

 No/Unknown

2164 (96.43)

230 (93.88)

1934 (96.75)

 

456 (94.61)

227 (94.19)

229 (95.02)

 

CDS + CT

   

0.019

   

0.659

 Yes

46 (2.05)

10 (4.08)

36 (1.80)

 

14 (2.9)

8 (3.32)

6 (2.49)

 

 No

1215 (54.14)

119 (48.57)

1096 (54.83)

 

247 (51.24)

119 (49.38)

128 (53.11)

 

 Unknown

983 (43.81)

116 (47.35)

867 (43.37)

 

221 (45.85)

114 (47.30)

107 (44.40)

 
  1. CDS: Cancer-directed surgery, RT: Radiothrapy, CT: Chemothrapy, CSS: Cancer-specific survival, OS: Overall survival, PSM: Propensity Score Matching.